Literature DB >> 17532476

TLR2-mediated cell stimulation in bacterial vaginosis.

Debra Mares1, Jose A Simoes, Richard M Novak, Gregory T Spear.   

Abstract

Bacterial vaginosis (BV) is associated with preterm labor, pelvic inflammatory disease (PID) and increased HIV acquisition, although the pathways that mediate these pathological effects have not been elucidated. To determine the presence of Toll-like receptor (TLR)-ligands and their specificity in BV, genital tract fluids were collected from women with and without BV by cervicovaginal lavage (CVL). The CVL samples were evaluated for their ability to stimulate secretion of proinflammatory cytokines and to activate NFkappaB and the HIV long terminal repeat (LTR), indicators of TLR activation, in human monocytic cells. Stimulation with BV CVLs induced higher levels of IL-8 and TNFalpha secretion, as well as higher levels of HIV LTR and NFkappaB activation, than CVLs from women with normal healthy bacterial flora. To identify which TLRs were important in BV, 293 cells expressing specific TLRs were exposed to CVL samples. BV CVLs induced higher IL-8 secretion by cells expressing TLR2 than CVLs from women without BV. Surprisingly, BV CVLs did not stimulate cells expressing TLR4/MD2, although these cells responded to purified lipopolysaccharide (LPS), a TLR4 ligand. BV CVLs, in cells expressing TLR2, also activated the HIV LTR. Thus, these studies show that soluble factor(s) present in the lower genital tract of women with BV activate cells via TLR2, identifying a pathway through which BV may mediate adverse effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532476      PMCID: PMC2254576          DOI: 10.1016/j.jri.2007.04.004

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  40 in total

Review 1.  Bacterial vaginosis.

Authors:  J D Sobel
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

Authors:  Roberta B Ness; Kevin E Kip; Sharon L Hillier; David E Soper; Carol A Stamm; Richard L Sweet; Peter Rice; Holly E Richter
Journal:  Am J Epidemiol       Date:  2005-08-10       Impact factor: 4.897

4.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species.

Authors:  M A Antonio; S E Hawes; S L Hillier
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Authors:  F X Zhang; C J Kirschning; R Mancinelli; X P Xu; Y Jin; E Faure; A Mantovani; M Rothe; M Muzio; M Arditi
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

7.  Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1.

Authors:  G G Olinger; F B Hashemi; B E Sha; G T Spear
Journal:  AIDS       Date:  1999-10-01       Impact factor: 4.177

8.  Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation?

Authors:  Mark A Klebanoff; Sharon L Hillier; Robert P Nugent; Cora A MacPherson; John C Hauth; J Christopher Carey; Margaret Harper; Ronald J Wapner; Wayne Trout; Atef Moawad; Kenneth J Leveno; Menachem Miodovnik; Baha M Sibai; J Peter Vandorsten; Mitchell P Dombrowski; Mary J O'Sullivan; Michael Varner; Oded Langer
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

9.  Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB.

Authors:  S J Klebanoff; D H Watts; C Mehlin; C M Headley
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

10.  Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa.

Authors:  Edward Demba; Linda Morison; Maarten Schim van der Loeff; Akum A Awasana; Euphemia Gooding; Robin Bailey; Philippe Mayaud; Beryl West
Journal:  BMC Infect Dis       Date:  2005-03-09       Impact factor: 3.090

View more
  21 in total

1.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

2.  Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.

Authors:  Jeanne M Marrazzo; Tina L Fiedler; Sujatha Srinivasan; Katherine K Thomas; Congzhou Liu; Daisy Ko; Hu Xie; Misty Saracino; David N Fredricks
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

Review 3.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

4.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

5.  Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Authors:  Timothy M Hanley; Gregory A Viglianti
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

Review 6.  Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.

Authors:  Florian Hladik; Gustavo F Doncel
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

7.  Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens.

Authors:  Juan C Hernández; Jose Arteaga; Stéphane Paul; Ajit Kumar; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2011-04-20       Impact factor: 2.205

8.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

9.  Effect of mucosal fluid from women with bacterial vaginosis on HIV trans-infection mediated by dendritic cells.

Authors:  Elizabeth P St John; M Reza Zariffard; Jeffrey A Martinson; Jose A Simoes; Alan L Landay; Gregory T Spear
Journal:  Virology       Date:  2008-12-30       Impact factor: 3.616

10.  The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry.

Authors:  John J Schellenberg; Francis A Plummer
Journal:  Int J Inflam       Date:  2012-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.